«However, many patients do not respond
because myeloid derived suppressor cells (MDSCs), a type of inhibitory cell, are present in the tumour microenvironment.»
Not exact matches
So if researchers think that an individual drug for, say, chronic
myeloid leukemia might work against a different kind of tumor
because the two illnesses share similar biological underpinnings, they have to conduct a whole new clinical trial and go through the approval process all over again for the second condition.
«
Myeloid cells are immune cells that are attracting attention
because they can infiltrate a broad range of tumors.
Participants are being asked to take part in this research study
because they have either relapsed or refractory acute
myeloid leukemia (AML).
Gleevec works so well in chronic
myeloid leukemia
because it turns off a tyrosine kinase that dramatically reverses the cancer process.»